No black box warning on record for Myqorzo

As of the latest FDA labeling reviewed, Myqorzo (AFICAMTEN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Myqorzo medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of Heart Failure : Consider decreasing dose or dose interruption in patients with serious intercurrent illness. ( 2.2 , 5.1 ) Drug Interactions Leading to Increased Risk of Heart Failure or Loss of Effectiveness: Advise patients of the potential for drug interactions. ( 2.3 , 5.3 , 17 ) 5.1 Heart Failure MYQORZO reduces cardiac contractility, which can reduce LVEF a

No black box warning on record for Myqorzo

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Risk of Heart Failure : Consider decreasing dose or dose interruption in patients with serious intercurrent illness. ( 2.2 , 5.1 ) Drug Interactions Leading to Increased Risk of Heart Failure or Loss of Effectiveness: Advise patients of the potential for drug interactions. ( 2.3 , 5.3 , 17 ) 5.1 Heart Failure MYQORZO reduces cardiac contractility, which can reduce LVEF a

Myqorzo Black Box Warning

No black box warning on record for Myqorzo

Other warnings & precautions

Myqorzo Black Box Warning

No black box warning on record for Myqorzo

Other warnings & precautions